philipn / TOGETHER Trial ce47cb2cabb4e86ad8f16858c02ddd05ea5fc7af

Create Draft
Linking Fluvoxamine
Review changes View this version of the page
You can also use the and keys
Deletions are marked like this Additions are marked like this

The TOGETHER Trial is a clinical trial platform evaluating repurposed drugs for early treatment of COVID-19.  The TOGETHER Trial's aim is to discover if existing medications can be used to treat people with early-diagnosed COVID-19.

The TOGETHER Trial was initiated on June of 2020. On January 20, 2021, TOGETHER enrolled its first patient.

The TOGETHER Trial is a multi-platform, randomized, adaptive trial. The co-principal investigators of TOGETHER are Dr. Edward Mills and Dr. Gilmar Reis.

Drugs trialed

  • Hydroxychloroquine - effect not found, arm stopped.
  • Lopinavir/Ritonavir - effect not found, arm stopped.
  • Ivermectin - effect not found, arm stopped.
  • Metformin - effect not found, arm stopped.
  • Fluvoxamine - intervention found effective.
  • Peginterferon Lambda - intervention found effective.
  • Doxazosin - recruitment paused.

Links

The TOGETHER Trial is a clinical trial platform evaluating repurposed drugs for early treatment of COVID-19.  The TOGETHER Trial's aim is to discover if existing medications can be used to treat people with early-diagnosed COVID-19.

The TOGETHER Trial was initiated on June of 2020. On January 20, 2021, TOGETHER enrolled its first patient.

The TOGETHER Trial is a multi-platform, randomized, adaptive trial. The co-principal investigators of TOGETHER are Dr. Edward Mills and Dr. Gilmar Reis.

Drugs trialed

  • Hydroxychloroquine - effect not found, arm stopped.
  • Lopinavir/Ritonavir - effect not found, arm stopped.
  • Ivermectin - effect not found, arm stopped.
  • Metformin - effect not found, arm stopped.
  • Fluvoxamine - intervention found effective.
  • Peginterferon Lambda - intervention found effective.
  • Doxazosin - recruitment paused.

Links
Create Draft
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.